Medicare HIT Incentives for the Community Oncology Practices

WHO:   Community oncologists, practice administrators, executive directors, nurses and other community oncology staff

WHAT:  Informative Webinar focusing on Medicare Health Information Technology (HIT) stimulus:

• A status report of standards for qualified electronic health records (EHR) 
• A status report on meaningful use requirements as defined by the Office of the National Coordinator for Health Information Technology (ONCHIT) at the Secretariat of Health & Human Services (HHS)
• Setting standards
• Which standards apply to oncology-specific EHRs

WHEN:           2 p.m. EDT, Friday, July 10, 2009

SPEAKERS:  Matt Brow, vice president, Government Relations & Public Policy, US Oncology
                       Cindy Chavez, vice president, iKnowMed, US Oncology

REGISTER:   www.opspharmacist.com/HITStimulus

CONTACT:   (866) 216-5053 or visit www.usoncology.com.

WHY:            With the signing of the American Recovery and Reinvestment Act (ARRA, a.k.a. the stimulus package), allocating approximately $20 billion towards electronic health record (EHR) adoption, physicians who demonstrate meaningful use of certified EHRs could be eligible for up to $44,000 in incentives over five years. This informative Webinar will help to educate physicians on how this stimulus can affect health care information technology plans for community-based oncology practices. 

About iKnowMed™
Designed in 1996, iKnowMed is a web-based oncology-specific electronic health record (EHR) system designed by oncologists for oncologists. In 2004, US Oncology, Inc., supporting the nation’s foremost cancer research and treatment network, acquired iKnowMed, further enhancing the technology through comprehensive collaboration between community-based oncology physicians. Today’s iKnowMed goes beyond delivering standard EHR features by leveraging technology that helps physicians focus on clinical excellence and cost effectiveness in community cancer care. The system includes the ability to connect to Level I evidence-based medicine pathways through US Oncology’s pay-for-performance solution, Innovent Oncology, and the ability to match patients to appropriate clinical trials through US Oncology Research. For more information call (866) 216-5053 or visit www.usoncology.com.
 
About US Oncology
US Oncology, Inc., headquartered in The Woodlands, Texas, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers, to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation’s foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology uses its expertise to support every aspect of the cancer care delivery system—from drug development to distribution and outcomes measurement—enabling the company to help increase the efficiency and safety of cancer care. According to the company’s last quarterly earnings report, US Oncology is affiliated with 1,227 physicians operating in 468 locations, including 95 radiation oncology facilities in 39 states. For more information, visit the company’s Web site, www.usoncology.com.
 

Media Contact:
Jennifer Horspool
(281) 863-6739 
Jennifer.Horspool@usoncology.com

# # #